Literature DB >> 10497252

Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2.

L Q Benson1, M R Coon, L M Krueger, G C Han, A A Sarnaik, D S Wechsler.   

Abstract

MXI1, a member of the MAD family of Myc antagonists, encodes a transcription factor whose expression must be tightly regulated to maintain normal cell growth and differentiation. To more closely investigate the transcriptional regulation of the human MXI1 gene, we have cloned and characterized the MXI1 promoter. After clarification of the 5'- and 3'-untranslated regions of the cDNA (indicating that the true length of the MXI1 transcript is 2643 base pairs), we identified two transcription initiation sites. We subsequently isolated the MXI1 promoter, which is GC-rich and lacks a TATA box. Although it contains at least six potential initiator sequences, functional studies indicate the proximal two initiator sequences in combination with nearby Sp1 and MED-1 sites together account for virtually all promoter activity. We also demonstrate that MXI1 promoter activity is repressed by high levels of AP2. These studies provide further insight into the complex regulatory mechanisms governing MXI1 gene expression and its role in cellular differentiation and tumor suppression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497252     DOI: 10.1074/jbc.274.40.28794

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.

Authors:  O Nyormoi; Z Wang; D Doan; M Ruiz; D McConkey; M Bar-Eli
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  LXR-α selectively reprogrammes cancer cells to enter into apoptosis.

Authors:  Aanchal Mehrotra; Deepak Kaul; Kusum Joshi
Journal:  Mol Cell Biochem       Date:  2010-12-02       Impact factor: 3.396

3.  Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2).

Authors:  Yong Xu; Sureerut Porntadavity; Daret K St Clair
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

4.  Mxi1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas.

Authors:  Lars D Engstrom; Andrew S Youkilis; Judith L Gorelick; Datong Zheng; Valerie Ackley; Christy A Petroff; Linda Q Benson; Melissa R Coon; Xiaoxiang Zhu; Samir M Hanash; Daniel S Wechsler
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

5.  Human promoter genomic composition demonstrates non-random groupings that reflect general cellular function.

Authors:  Markey C McNutt; Ron Tongbai; Wenwu Cui; Irene Collins; Wendy J Freebern; Idalia Montano; Cynthia M Haggerty; Gvr Chandramouli; Kevin Gardner
Journal:  BMC Bioinformatics       Date:  2005-10-18       Impact factor: 3.169

6.  p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells.

Authors:  Emilie Horvilleur; Matthieu Bauer; David Goldschneider; Xénia Mergui; Alix de la Motte; Jean Bénard; Sétha Douc-Rasy; David Cappellen
Journal:  Nucleic Acids Res       Date:  2008-06-25       Impact factor: 16.971

7.  S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer.

Authors:  Yumei Huang; Kaishun Hu; Sheng Zhang; Xiaorong Dong; Zhongyuan Yin; Rui Meng; Yingchao Zhao; Xiaofang Dai; Tao Zhang; Kunyu Yang; Li Liu; Kai Huang; Shaojun Shi; Yu Zhang; Junjie Chen; Gang Wu; Shuangbing Xu
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

8.  Regulation of the MAD1 promoter by G-CSF.

Authors:  Kan Jiang; Nadine Hein; Kolja Eckert; Juliane Lüscher-Firzlaff; Bernhard Lüscher
Journal:  Nucleic Acids Res       Date:  2008-01-18       Impact factor: 16.971

9.  Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network.

Authors:  J K R Boult; P Tanière; M T Hallissey; M J Campbell; C Tselepis
Journal:  Br J Cancer       Date:  2008-05-20       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.